Dr. Zhang’s research was focused on host factors that regulate herpesvirus-associated cancers. His current research interest focuses on MYCN-amplified neuroblastoma (NB), which is one of the deadliest subtypes of pediatric cancer. Ongoing study will characterize the ability of MYCN to suppress ferroptosis in neuroblastoma and identify the synthetic lethal ferroptosis resistance mechanisms in MYCN-amplified neuroblastoma, and evaluated novel ferroptotic combination therapies in MYCN-amplified neuroblastoma mouse models.